Current Medical Research and Opinion
Volume 38, 2022 - Issue 1
Cardiovascular Medicine
Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease
Craig I. Colemana Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA;b Evidence-based Practice Center, Hartford Hospital, Hartford, Connecticut, USACorrespondence[email protected]
https://orcid.org/0000-0003-4868-7158
https://orcid.org/0000-0003-4868-7158, Akshay A. Kharatc Real World Value and Evidence, Janssen Scientific Affairs LLC, Titusville, New Jersey, USAhttps://orcid.org/0000-0002-1056-9466
https://orcid.org/0000-0002-1056-9466, & William L. Bakera Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA;b Evidence-based Practice Center, Hartford Hospital, Hartford, Connecticut, USAhttps://orcid.org/0000-0003-2172-0931
https://orcid.org/0000-0003-2172-0931